• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Chutes and Ladders

parachute chutes
Biotech

Eric Topol boards Flagship as advisor—Chutes & Ladders

Eric Topol boards Flagship as advisor. Idorsia CEO hits the exit. Mestag adds $40 million, two new C-suiters.
Darren Incorvaia , Zoey Becker , Will Maddox Mar 20, 2026 8:30am
reset button

Phage-focused BiomX reset may include defense sector pivot

Mar 19, 2026 11:00am
F1 Racetrack

R1 debuts with $77.5M to advance kidney disease treatment

Mar 17, 2026 7:00am
exit sign
Favicon Fierce Pharma

Idorsia shares sink after CEO's abrupt departure

Mar 16, 2026 11:00am
Parachute over a desert

BioNTech founders to pioneer new company—Chutes & Ladders

Mar 13, 2026 8:30am
Ugur Sahin

BioNTech's CEO, CMO will depart to set up next-gen mRNA company

Mar 10, 2026 6:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings